Rheumatic Heart Disease - stuck in Prosthetic Valve
DOI:
https://doi.org/10.37628/ijcn.v3i1.654Abstract
Rheumatic fever (RF) and rheumatic heart disease (RHD) endure to be a main health danger in most emerging countries as well as periodically in progressive economies. The healing process of rheumatic carditis results in varying degrees of fibrosis and valve damage Elevated erythrocyte sedimentation rate (ESR) is a nonspecific evidence for an active GAS infection. It is elevated in acute RF but can be normal if the patient has congestive failure and can be high in the presence of anemia. GAS has remained sensitive to penicillin and should have been eradicated. Availability of a vaccine, which could prevent streptococcal infection, is essential for primary prevention of RF. Prevalence of RF/RHD has been attributed to overcrowding and unhygienic living related to low socio-economic status.References
http://burmachildren.com/who-we- are/conditions-we- treat/cardiac-disease/
https://www.nhlbi.nih.gov/health/health-topics/topics/hvd/trials
Global Atlas on Cardiovascular Disease Prevention and Control. Mendis S, Puska P, Norrving B editors.
World Health Organization (in collaboration with the World Heart Federation and World Stroke Organization),
Geneva 2011.
http://emedicine.medscape.com/article/1962779-overview#a2.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724245/)
Horstkotte D, Burckardt D. Prosthetic valve thrombosis. J Heart Valve Dis.1995;4:141–53.
Laplace G, Lafitte S, Labe`que JN, et al. Clinical significance of early thrombosis after prosthetic mitral valve
replacement. J Am Coll Cardiol 2004;43:1283–90.
Deviri E, Sareli P, Wisenbaugh T, et al. Obstruction of mechanical heart valve prostheses: clinical aspect and
surgical management. J Am Coll Cardiol 1991;17:646–50.
Heras M, Chesebro JH, Fuster V, et al. High risk of thromboemboli early after bioprosthetic cardiac valve
replacement. J Am Coll Cardiol 1995;25:1111–9.
Cribier A, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for
the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol. 2004;43:698
–703.
. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, Buller CE, Pasupati S,
Lichtenstein S. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation.
;113: 842–850.
Grube E, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the
second- and current thirdgeneration self-expanding CoreValve prosthesis: device success and 30-day clinical
outcome. J Am Coll Cardiol. 2007;50:69 –76.
Lichtenstein SV, Cheung A, Ye J, Thompson CR, Carere RG, Pasupati S, Webb JG. Transapical
transcatheter aortic valve implantation in humans: initial clinical experience. Circulation. 2006;114:591–596.
Walther T, et all. Transapical minimally invasive aortic valve implantation: multicenter
experience. Circulation. 2007;116(suppl):I-240–I- 245.
Philippe Pibarot,Jean G. Prosthetic Heart Valves Selection of the Optimal Prosthesis and Long-Term
Management .Circulation. 2009;119:1034-1048.
Montorsi P, Cavoretto D, Repossini A, et al. Valve design characteristics and cine-fluoroscopic appearance
of five currently available bileafiet prosthetic heart valves. Am J Cardiac Imag 1996;10:29–41.
Iung B, Cormier B, Dadez E, et al. Small abnormal echoes after mitral valve
replacement with bileaflet mechanical prostheses: predisposing factors and effect
on thromboembolism. J Heart Valve Dis 1993;2:259–66
Barbetseas J, Nagueh SF, Pitsavos C, et al. Differentiating thrombus from Pannus formation in obstructed
mechanical prosthetic valves: an evaluation of clinical transthoracic and TEE parameters. J Am Coll Cardiol
;32:1410–7
https://www.cryolife.com/products/on-x- heart-valves/heart- valve-design- features/
Rajesh Rajan, Velayudhan Nair Vasantha Krishnakumar, Charantharayil Gopalan Bahuleyan ,Padmanabhan
Balachandran Nair.Mitral Prosthetic Valve Obstruction and Its Complications.Int Cardiovasc Res
J.2015;9(4):247-250.
Hsiao-Ching Cheng, Pei-Luen Kang1, and Shoa-Lin Lin.Management of Mechanical Heart Valve
Obstruction. J Intern Med Taiwan 2008; 19: 379-386
Arun prasath Palamalai,1 Sujal Nikhil Ramakrishnan,1 Anand Kumar gopi.Safety and Efficacy of
Thrombolysis for Stuck Valve in Rheumatic Heart Disease - A Single Centre Experience . India journal of the
American college of cardiology , 2015;65:1 7.
https://watermark.silverchair.com
. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and
prevention. Ann Thorac Surg. 2005; 79:1072–1080.
